Jungmin Jo

8PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 18, 2026
Occult pT2-4 disease and postoperative loss of full-dose cisplatin eligibility in CT-staged cT≤1/cN0 upper tract urothelial carcinoma.

|Apr 07, 2026
Perception of Family Genetic Testing for Hereditary Breast and Ovarian Cancer: A Survey of Patients and General Public.

Eun Jeong Lee, Ji Young Kim, Jiwoo An

|Jan 10, 2026
Correction: Jo et al. Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury. J. Clin. Med. 2022, 11, 7196.

Jungmin Jo, Jung-Yeon Kim, Jaechan Leem

|Dec 11, 2022
Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury.

Jungmin Jo, Jung-Yeon Kim, Jaechan Leem

|Dec 17, 2020
Inhibition of p300 by Garcinol Protects against Cisplatin-Induced Acute Kidney Injury through Suppression of Oxidative Stress, Inflammation, and Tubular Cell Death in Mice.

Jung-Yeon Kim, Jungmin Jo, Jaechan Leem

|Dec 09, 2020
Kahweol Ameliorates Cisplatin-Induced Acute Kidney Injury through Pleiotropic Effects in Mice.

Jung-Yeon Kim, Jungmin Jo, Jaechan Leem

Pageof 2

Frequent Collaborators

6 joint publications

Jaechan Leem

1 joint publications

Jung-Yeon Kim

1 joint publications

Jae-Hyung Park

1 joint publications

Kwan-Kyu Park